FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Free FDA Notices
Comments Sought on Bio Labeling Requirements
07/22/2003
Federal Register
Notice: FDA is seeking public comment on the information collection requirements related to certain biologics labeling requirements. Comments should be submitted by 9/22. To view this notice, click
here
.
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
NEWSROOM CLOSED FOR THE HOLIDAYS
CDER Right-to-Try Summaries Can Go Thru Portal
Guide on Tech Specs for NASH Drug Data Sets
FDA Promotes Centralized Statistical Trial Monitoring
McKinsey & Co. Pays $650 Million in Opioid Case
Zimmer Biomet Stemless Shoulder System
FDA Sees New Ocaliva Liver Injuries
Keros Halts Some Dosing in Cibotercept Trial
LATEST NEWS
Read More
Human Drugs
NEWSROOM CLOSED FOR THE HOLIDAYS
Read More
Human Drugs
CDER Right-to-Try Summaries Can Go Thru Portal
Read More
Human Drugs
Guide on Tech Specs for NASH Drug Data Sets
Read More
Human Drugs
FDA Promotes Centralized Statistical Trial Monitoring
FDA Webview Free Daily e-Newsletter
Free Sign-Up
